Full-Time

Oncology Account Manager

Deadline 8/21/27
Eugia US

Eugia US

Sterile injectable medicines manufacturer

Compensation Overview

$170k - $180k/yr

+ Annual bonus + Long-term incentive plan

No H1B Sponsorship

Atlanta, GA, USA

In Person

Must live within the Atlanta territory; business travel of 40% or more is regularly required.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
Sales
Word/Pages/Docs
Excel/Numbers/Sheets
Microsoft Outlook
Requirements
  • At least 3 current years of selling experience in the Oncology, Immunology, Hematology, or Rare Disease therapeutic market is preferred; Oncology registered nurses, physician assistants, nurse practitioners, or equivalent candidates may apply.
  • A proven track record of successful sales results and the ability to meet or exceed objectives, including demonstrated success selling in a territory with zero to limited impact from a co-promotion or POD selling environment.
  • Computer skills using Word, Excel, Outlook, and PowerPoint.
  • Must live within the assigned Atlanta territory.
  • Must be legally authorized to work in the United States without restriction.
  • Must be willing to take a drug test and post-offer physical, if required.
  • Must be 18 years of age or older.
  • Must possess a valid United States driver's license, a car, and a driving record compliant with company standards.
  • A bachelor's degree from an accredited institution is required.
Responsibilities
  • Achieve sales goals and market-share targets in the assigned territory through the development, maintenance, and enhancement of key customer relationships while adhering to regulatory and promotional guidelines.
  • Communicate appropriate technical, therapeutic, disease-state, and product information to customers to promote appropriate on-label use of approved products within the territory.
  • Use effective selling techniques and marketing strategies to create and expand demand for promoted brands.
  • Develop and coordinate physician advocates for promoted oncology products.
  • Arrange and coordinate promotional programs within promotional and regulatory guidelines.
  • Conduct field activities including lunch-and-learns, customer in-services, and tumor-board participation.
  • Serve as a resource for oncology organizations, teaching institutions, physicians, oncology nurses, pharmacy directors, therapeutic groups, and related customers.
  • Communicate regularly with the Regional Sales Director, peers, Account Managers, internal and external partners, and clients to optimize resources and exceed customer expectations.
  • Comply with OIG, pharmaceutical, and corporate policies, procedures, and guidelines.
  • Complete expense reports and other required administrative reports accurately and on time according to corporate policies.
  • Attend training programs, conventions, and symposiums.
  • Complete and maintain territory analyses, including monthly forecasts, patient trackers, and call metrics.
  • Present and demonstrate the ability to attain and exceed sales goals, execute the complete sales process, and demonstrate personal accountability and commitment to business sales objectives.
  • Manage the territory to achieve sales targets while staying within approved budgets.
Desired Qualifications
  • A major in Biological Science and/or Chemistry is preferred.
  • Some nights and weekends are required.
  • Business travel by air or car of 40% or more is regularly required.

Eugia US is a pharmaceutical company focused on generic sterile injectable medicines. Scientific, engineering, production, quality, regulatory, supply-chain, and commercial teams support the product lifecycle. It develops, manufactures, markets, and distributes institutional products used by hospitals and pharmacies. The profile is Eugia's United States operation and its institutional medicines business. Roles include formulation, manufacturing, laboratory work, validation, maintenance, quality, regulatory affairs, sales, and operations. Its workforce connects frontline delivery with the specialist, operational, technical, and business teams that support the organization.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

New Jersey

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Pomalidomide launched March 4, 2026, expanding Eugia's U.S. oncology lineup.
  • Everolimus approval positions Unit-I for Q1 FY27 commercialization and fresh revenue.
  • Unit-I received only four FDA observations in March 2026, showing stronger compliance.

What critics are saying

  • FDA classified Eugia Unit-III OAI on June 12, 2026 after 11 findings.
  • OAI blocks pending approvals from Unit-III and delays 2026-27 injectable launches.
  • An import alert on Unit-III would cripple U.S. sterile revenue and destroy credibility.

What makes Eugia US unique

  • Eugia Pharma Specialities led Aurobindo's 184th ANDA approval on February 26, 2026.
  • Unit-I launched Pomalidomide capsules in March 2026, entering U.S. oncology generics.
  • Eugia Unit-I won Everolimus tablet approval, targeting a $78 million market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

401(k) Company Match

Paid Vacation

Paid Holidays